Ryan Zimmerman
Stock Analyst at BTIG
(4.00)
# 594
Out of 4,996 analysts
190
Total ratings
51.88%
Success rate
10.94%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORGO Organogenesis Holdings | Reiterates: Buy | $7 | $4.10 | +70.73% | 7 | Sep 26, 2025 | |
| VCEL Vericel | Downgrades: Neutral | n/a | $30.23 | - | 9 | Sep 17, 2025 | |
| PRCT PROCEPT BioRobotics | Reiterates: Neutral | n/a | $36.66 | - | 2 | Sep 16, 2025 | |
| GKOS Glaukos | Reiterates: Buy | $118 | $79.92 | +47.65% | 11 | Sep 10, 2025 | |
| SI Shoulder Innovations | Reiterates: Buy | $23 | $12.10 | +90.08% | 1 | Sep 9, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $39 | $18.27 | +113.46% | 8 | Aug 6, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $566 → $571 | $441.12 | +29.44% | 18 | Jul 23, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $145 → $148 | $133.55 | +10.82% | 7 | Jul 14, 2025 | |
| RXST RxSight | Downgrades: Neutral | n/a | $9.03 | - | 5 | Jul 9, 2025 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $55.70 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $232 → $270 | $253.37 | +6.56% | 19 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $383 → $394 | $369.02 | +6.77% | 15 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.73 | +478.03% | 4 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $106 | $73.92 | +43.40% | 11 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $13.20 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $126 | $98.24 | +28.26% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $72.46 | +38.01% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $71.37 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $26.80 | +97.76% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.64 | +367.73% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.66 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.20 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.10 | +90.93% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.46 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.29 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $13.78 | +103.19% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $141.48 | +41.36% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $318.00 | +10.06% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $94.22 | +35.85% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.33 | +21.65% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $67.21 | +35.40% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.89 | +134.77% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $4.93 | +964.91% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.16 | - | 3 | Apr 2, 2020 |
Organogenesis Holdings
Sep 26, 2025
Reiterates: Buy
Price Target: $7
Current: $4.10
Upside: +70.73%
Vericel
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $30.23
Upside: -
PROCEPT BioRobotics
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $36.66
Upside: -
Glaukos
Sep 10, 2025
Reiterates: Buy
Price Target: $118
Current: $79.92
Upside: +47.65%
Shoulder Innovations
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $12.10
Upside: +90.08%
OrthoPediatrics
Aug 6, 2025
Maintains: Buy
Price Target: $40 → $39
Current: $18.27
Upside: +113.46%
Intuitive Surgical
Jul 23, 2025
Maintains: Buy
Price Target: $566 → $571
Current: $441.12
Upside: +29.44%
Abbott Laboratories
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $133.55
Upside: +10.82%
RxSight
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $9.03
Upside: -
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $55.70
Upside: -
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $253.37
Upside: +6.56%
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $369.02
Upside: +6.77%
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $1.73
Upside: +478.03%
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $73.92
Upside: +43.40%
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $13.20
Upside: -
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $98.24
Upside: +28.26%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $72.46
Upside: +38.01%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $71.37
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $26.80
Upside: +97.76%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.64
Upside: +367.73%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.66
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.20
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.10
Upside: +90.93%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.46
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $14.29
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $13.78
Upside: +103.19%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $141.48
Upside: +41.36%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $318.00
Upside: +10.06%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $94.22
Upside: +35.85%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.33
Upside: +21.65%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $67.21
Upside: +35.40%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.89
Upside: +134.77%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $4.93
Upside: +964.91%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $17.16
Upside: -